Noven Recalls Daytrana Patches Due to Defective Delivery System
Noven Pharmaceuticals is recalling 231,270 Daytrana patches because the release liner may be difficult to remove.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the hazard is a mechanical defect affecting the ease of removing the liner rather than a direct toxicological or structural safety failure, fitting the criteria for moderate severity.
Plain-English summary
Noven Pharmaceuticals, Inc. is recalling 231,270 units of Daytrana (methylphenidate) transdermal system patches. The affected product is Lot #53823, with an expiration date of 08/12. The patches are packaged in 30-count boxes and were distributed nationwide and in Puerto Rico.
The recall was initiated because the patches failed to meet specifications for mechanical peel force and z-statistic values. These defects relate to the patient's ability to remove the release liner from the patch adhesive prior to administration. The issue may make it difficult for patients to properly prepare the patch for use.
Consumers who have this specific lot of Daytrana should stop using the product and contact their healthcare provider or Noven Pharmaceuticals for instructions on how to return the product for a refund.
The recalled product
- Product
- DAYTRANA (METHYLPHENIDATE)
- Brand
- DAYTRANA
- Manufacturer
- Noven Pharmaceuticals, Inc.
- Category
- Drug — Transdermal Patch
- Affected units
- 231,270
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #53823
- Exp 08/12
Distribution
Part of a larger recall action
This product is one of 3 recalled by Noven Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same brand · DAYTRANA
- ModerateDaytrana Methylphenidate Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29
- HighDaytrana Methylphenidate Patches Recalled for Defective Transdermal Delivery System
FDA (Drugs) · 2023-03-29
- HighDaytrana Methylphenidate Transdermal Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29
- HighDaytrana methylphenidate patches recalled for defective delivery system
FDA (Drugs) · 2023-03-29
- HighDaytrana transdermal methylphenidate patches recalled for adhesive defect
FDA (Drugs) · 2022-12-07
Same manufacturer · Noven Pharmaceuticals, Inc.
See all →- HighPrescription Dextroamphetamine Patches Recalled for Defective Adhesive System
FDA (Drugs) · 2024-11-27
- HighMethylphenidate Patch Recall: Defective Delivery System and Adhesive Issues
FDA (Drugs) · 2022-07-06
Same hazard · defective delivery system
See all →- ModerateCetrorelix injection kits recalled over missing or duplicated needles inside
FDA (Drugs) · 2026-02-18
- HighAIRSUPRA Albuterol and Budesonide Inhalation Aerosol Recalled for Defective Delivery System
FDA (Drugs) · 2025-05-28
- HighLorazepam Oral Syringes Recalled Due to Defective Delivery System Causing Leakage
FDA (Drugs) · 2025-03-12
- ModerateVarithena Administration Pack Recalled Due to Incorrect Syringe Connector Type
FDA (Drugs) · 2024-12-18
- ModerateDrug Recall: Incorrect Syringe in ZYNRELEF Anesthetic Delivery Kits
FDA (Drugs) · 2022-08-24